Drugs for Colo-rectal cancer - Management

Floxuridine Injection is an antineoplastic agent, prescribed for gastrointestinal adenocarcinoma.

Fluorouracil is an antimetabolite, prescribed for certain types of cancer such as colon, rectal, breast, stomach and pancreatic cancer.

Levoleucovorin is a folic acid derivative, used as an adjuvant in chemotherapy for treating patients with osteosarcoma and colorectal cancer.

Mechlorethamine is an alkylating agent, prescribed for certain types of cancer.

Panitumumab Injection is a monoclonal antibody, prescribed for colon or rectal cancer.

Pembrolizumab injection is prescribed to treat different types of cancer such as • Melanoma or skin cancer • Non-Small-Cell lung cancer (NSCLC) • Head and neck cancer • Urothelial carcinoma (Cancer of the bladder and urinary tract) • Hodgkin’s disease (Cancer of the immune system) • Colorectal cancer (Cancer of the large intestine) Pembrolizumab is a monoclonal antibody chosen to treat cancers in the following situations.

Ramucirumab is used to treat stomach cancer or cancer at the junction of the stomach and esophagus, in patients with advanced or cancer that has migrated to other body parts.

Tegafur and uracil combination drugs are used to treat metastatic colorectal cancer, a condition in which the cancer cells have moved to other body parts in adult patients.

Trifluridine and tipiracil are used in combination to treat colorectal cancer in adult patients whose cancer condition has spread to other body parts or who cannot tolerate other cancer treatments.

Ziv-Aflibercept is a recombinant fusion protein, prescribed for metastatic colorectal cancer (mCRC) along with other medications.